Avience Biomedicals IPO
Price Band
₹196 – ₹208
Issue Size
₹30.24 Cr
Lot Size
600 shares
Min ₹2,49,600
Issue Dates
18 Jun – 22 Jun 2026
Listing Date
25 Jun 2026
About Avience Biomedicals Limited
Avience Biomedicals Limited is an ISO-certified company engaged in the manufacturing, supply and export of molecular diagnostic solutions, rapid test kits, biochemistry analyzers, hematology analyzers, molecular diagnostics products, medical devices and related healthcare solutions. The company serves pathology labs, microbiology labs, hospitals and research centers across India and overseas, operating primarily in B2B and B2G segments.
IPO Details
| Price Band | ₹196 – ₹208 |
| Face Value | ₹10 |
| Lot Size | 600 shares(Min ₹2,49,600) |
| Issue Size | ₹30.24 Cr |
| Fresh Issue | ₹30.24 Cr |
| Listed On | NSE |
Objects of the Issue
Part financing the capital expenditure towards setting up a new manufacturing unit at Medical Device Park, YEIDA, Uttar Pradesh; funding working capital requirements; and general corporate purposes.
Key Financial Metrics
EPS (Basic)
₹17.94
P/E Ratio
11.59x
ROE
22.38%
ROCE
16.99%
Debt / Equity
0.94
Financial Performance
| Particulars (₹ Cr) | FY24 |
|---|---|
| Revenue | 24.37 |
| EBITDA | 4.08 |
| PAT | 2.14 |
| Total Assets | 34.65 |
| Net Worth | 6.21 |
| Total Borrowings | 15.13 |
Valuation
Market Capitalisation
P/E Ratio
Promoter Holding
Public Holding
Lot Size & Allocation
Investment by Category
| Category | Lot Size | Min Investment | Max Investment |
|---|---|---|---|
| Retail (RII) | 2 × 600 | ₹2,49,600 | ₹2,49,600 |
Reservation / Allocation
| Category | Allocation | Cut-off |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 49.83% | No |
| NII (Non-Institutional Investors) | 15.09% | No |
| RII (Retail Individual Investors) | 35.08% | Yes |
Registrar & Lead Managers
Registrar
Lead Managers (1)
Important Dates
Community Discussion
Ask questions and share your thoughts about this IPO
Be the first to ask or share about Avience Biomedicals IPO